Olaris aims to fundamentally change how diseases are diagnosed and treated. With our pioneering metabolomics platform and machine learning algorithms, we produce personalized "Biomarkers of Response" (BoR) to readily differentiate drug responders (R) from non-responders (NR).We get the right drug to the right patient right away.